Area of research
Pulmonary and Respiratory Medicine · Molecular Biology
Research interest
Research interests include Lung Cancer Treatments and Mutations, RNA modifications and cancer, Cancer Genomics and Diagnostics, and Lung Cancer Diagnosis and Treatment.
Differential pre-malignant programs and microenvironment chart distinct paths to malignancy in human colorectal polyps
The Human Tumor Atlas Network: Charting Tumor Transitions across Space and Time at Single-Cell Resolution
Characteristics and Outcomes of Patients With Metastatic KRAS-Mutant Lung Adenocarcinomas: The Lung Cancer Mutation Consortium Experience
MET IHC Is a Poor Screen for MET Amplification or MET Exon 14 Mutations in Lung Adenocarcinomas: Data from a Tri-Institutional Cohort of the Lung Cancer Mutation Consortium
Comparative Treatment Outcomes for Patients With Idiopathic Subglottic Stenosis
<i>HER2</i> mutations in lung adenocarcinomas: A report from the Lung Cancer Mutation Consortium
Effect of expanded genomic testing in lung adenocarcinoma (LUCA) on survival benefit: The Lung Cancer Mutation Consortium II (LCMC II) experience.
Multi-institutional Oncogenic Driver Mutation Analysis in Lung Adenocarcinoma: The Lung Cancer Mutation Consortium Experience
Role of race in oncogenic driver prevalence and outcomes in lung adenocarcinoma: Results from the Lung Cancer Mutation Consortium
Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs
Characteristics of Lung Cancers Harboring <i>NRAS</i> Mutations
A multicenter effort to identify driver mutations and employ targeted therapy in patients with lung adenocarcinomas: The Lung Cancer Mutation Consortium (LCMC).